HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

3,7,8-tri-O-methylellagic acid

structure given in first source

Also Known As:

3,3',4-O-trimethylellagic acid; 3,3',4-tri-O-methylellagic acid

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Ellagic Acid: 702
        3,7,8-tri-O-methylellagic acid: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Ellagic Acid: 702
        3,7,8-tri-O-methylellagic acid: 1

Experts

1.	Dai, Yanping: 1 article (04/2014)
2.	Gao, Xiaoping: 1 article (04/2014)
3.	Wu, Jianming: 1 article (04/2014)
4.	Zou, Wenjun: 1 article (04/2014)

Related Diseases

1.

Blood Platelet Disorders (Thrombocytopathy)

04/24/2014 - "This is the first time that 3,3',4-tri-O-methylellagic acid or 3,3',4-tri-O-methylellagic acid-4'-O-β-d-xyloside are reported to induce megakaryopoiesis, suggesting a class of small molecules which differ from others non-peptidyl, and appears to have potential for clinical development as a therapeutic agent for patients with blood platelet disorders. "